Cutler Group’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-77
Closed 6313
2021
Q4
$0 Sell
77
-47
-38% -$630 ﹤0.01% 6385
2021
Q3
$2K Sell
124
-176
-59% -$3.17K ﹤0.01% 5164
2021
Q2
$6K Buy
+300
New +$6.04K ﹤0.01% 4372
2018
Q3
Sell
-50
Closed -$8K 4881
2018
Q2
$8K Hold
50
﹤0.01% 2850
2018
Q1
$12K Hold
50
﹤0.01% 2683
2017
Q4
$14K Hold
50
﹤0.01% 2896
2017
Q3
$15K Hold
50
﹤0.01% 3442
2017
Q2
$11K Sell
50
-88
-64% -$23K ﹤0.01% 4102
2017
Q1
$46K Buy
138
+88
+176% +$21.2K ﹤0.01% 2503
2016
Q4
$10K Hold
50
﹤0.01% 4248
2016
Q3
$17K Hold
50
﹤0.01% 3615
2016
Q2
$10K Hold
50
﹤0.01% 4192
2016
Q1
$13K Hold
50
﹤0.01% 3788
2015
Q4
$21K Buy
+50
New +$22.4K ﹤0.01% 3391

Other funds holding ACGN

Cutler Group's ACGN Position: Q1 2022 in Review

Cutler Group sold out of Aceragen Inc (ACGN) in Q1 2022, closing a stake of 77 shares.

Cutler Group first reported a position in ACGN in Q4 2015 and held it in 14 quarters. The position peaked at $46K in Q1 2017. 31 funds tracked by Wall St. Rank hold ACGN as of Q1 2022.

  • Cutler Group reported no remaining Aceragen Inc position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 77 Aceragen Inc shares in Q1 2022.
  • Cutler Group first reported a position in Aceragen Inc in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Aceragen Inc position peaked at $46K in Q1 2017.
  • 31 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.